• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜相关人类碳酸酐酶之间的结构比较为选择性抑制剂的药物设计提供了见解。

The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors.

作者信息

Alterio Vincenzo, Pan Peiwen, Parkkila Seppo, Buonanno Martina, Supuran Claudiu T, Monti Simona M, De Simone Giuseppina

机构信息

Institute of Biostructures and Bioimaging, CNR, Via Mezzocannone 16, 80134, Naples, Italy.

出版信息

Biopolymers. 2014 Jul;101(7):769-78. doi: 10.1002/bip.22456.

DOI:10.1002/bip.22456
PMID:24374484
Abstract

Carbonic anhydrase isoform XIV (CA XIV) is the last member of the human (h) CA family discovered so far, being localized in brain, kidneys, colon, small intestine, urinary bladder, liver, and spinal cord. It has recently been described as a possible drug target for treatment of epilepsy, some retinopathies as well as some skin tumors. Human carbonic anhydrase (hCA) XIV is a membrane-associated protein consisting of an N-terminal extracellular domain, a putative transmembrane region, and a small cytoplasmic tail. In this article, we report the expression, purification, and the crystallographic structure of the entire extracellular domain of this enzyme. The analysis of the structure revealed the typical α-CA fold, in which a 10-stranded β-sheet forms the core of the molecule, while the comparison with all the other membrane associated isoforms (hCAs IV, IX, and XII) allowed to identify the diverse oligomeric arrangement and the sequence and structural differences observed in the region 127-136 as the main factors to consider in the design of selective inhibitors for each one of the membrane associated α-CAs.

摘要

碳酸酐酶同工酶XIV(CA XIV)是迄今为止发现的人类(h)CA家族的最后一个成员,定位于脑、肾、结肠、小肠、膀胱、肝脏和脊髓。最近它被描述为治疗癫痫、某些视网膜病变以及某些皮肤肿瘤的潜在药物靶点。人碳酸酐酶(hCA)XIV是一种膜相关蛋白,由一个N端细胞外结构域、一个推定的跨膜区域和一个小的细胞质尾巴组成。在本文中,我们报道了该酶整个细胞外结构域的表达、纯化及晶体学结构。结构分析揭示了典型的α-CA折叠,其中一个10股β-折叠形成分子核心,而与所有其他膜相关同工型(hCAs IV、IX和XII)的比较使我们能够确定不同的寡聚排列以及在127-136区域观察到的序列和结构差异,这些是设计针对每种膜相关α-CA的选择性抑制剂时需要考虑的主要因素。

相似文献

1
The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors.膜相关人类碳酸酐酶之间的结构比较为选择性抑制剂的药物设计提供了见解。
Biopolymers. 2014 Jul;101(7):769-78. doi: 10.1002/bip.22456.
2
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.肿瘤相关的人类碳酸酐酶IX催化结构域的晶体结构
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16233-8. doi: 10.1073/pnas.0908301106. Epub 2009 Sep 14.
3
Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes.小鼠碳酸酐酶XIV胞外结构域的表达、测定及结构:对膜相关同工酶选择性抑制的意义
J Biol Chem. 2004 Feb 20;279(8):7223-8. doi: 10.1074/jbc.M310809200. Epub 2003 Dec 3.
4
Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.人碳酸酐酶XIII及其与抑制剂乙酰唑胺复合物的晶体结构
Proteins. 2009 Jan;74(1):164-75. doi: 10.1002/prot.22144.
5
X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.6-氨磺酰基糖精作为碳酸酐酶抑制剂的X射线晶体学和动力学研究。
Org Biomol Chem. 2015 Apr 7;13(13):4064-9. doi: 10.1039/c4ob02648a.
6
Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.碳酸酐酶激活剂。用L-和D-苯丙氨酸激活同工酶I、II、IV、VA、VII和XIV及其与同工酶II加合物的晶体学分析:酶活性位点内的立体特异性识别及其对药物设计的影响。
J Med Chem. 2006 May 18;49(10):3019-27. doi: 10.1021/jm0603320.
7
Membrane-bound carbonic anhydrases in osteoclasts.破骨细胞中的膜结合碳酸酐酶
Bone. 2007 Apr;40(4):1021-31. doi: 10.1016/j.bone.2006.11.028. Epub 2006 Dec 22.
8
Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.碳酸酐酶抑制剂。用阴离子抑制跨膜同工酶XII(癌症相关)和XIV。
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1532-7. doi: 10.1016/j.bmcl.2006.12.113. Epub 2007 Jan 13.
9
Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII.碳酸酐酶家族结构研究的最新进展:人碳酸酐酶 IX 和 CA XIII 的晶体结构。
Curr Pharm Des. 2010;16(29):3246-54. doi: 10.2174/138161210793429841.
10
Purification, enzymatic activity and inhibitor discovery for recombinant human carbonic anhydrase XIV.
J Biotechnol. 2016 Dec 20;240:31-42. doi: 10.1016/j.jbiotec.2016.10.018. Epub 2016 Oct 20.

引用本文的文献

1
Unraveling Protein-Metabolite Interactions in Precision Nutrition: A Case Study of Blueberry-Derived Metabolites Using Advanced Computational Methods.解析精准营养中的蛋白质-代谢物相互作用:使用先进计算方法对蓝莓衍生代谢物的案例研究。
Metabolites. 2024 Aug 3;14(8):430. doi: 10.3390/metabo14080430.
2
The production and biochemical characterization of α-carbonic anhydrase from Lactobacillus rhamnosus GG.鼠李糖乳杆菌 GG 中α-碳酸酐酶的生产和生化特性。
Appl Microbiol Biotechnol. 2022 Jun;106(11):4065-4074. doi: 10.1007/s00253-022-11990-3. Epub 2022 May 25.
3
Loss of luminal carbonic anhydrase XIV results in decreased biliary bicarbonate output, liver fibrosis, and cholangiocyte proliferation in mice.
腔道型碳酸酐酶 XIV 的缺失导致小鼠胆汁碳酸氢盐分泌减少、肝纤维化和胆管细胞增殖。
Pflugers Arch. 2022 May;474(5):529-539. doi: 10.1007/s00424-021-02659-3. Epub 2022 Feb 4.
4
Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives.碳酸酐酶抑制剂与癫痫:现状与未来展望。
Molecules. 2021 Oct 22;26(21):6380. doi: 10.3390/molecules26216380.
5
Post-translational modifications in tumor-associated carbonic anhydrases.肿瘤相关碳酸酐酶的翻译后修饰。
Amino Acids. 2022 Apr;54(4):543-558. doi: 10.1007/s00726-021-03063-y. Epub 2021 Aug 26.
6
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.重新考虑阴离子抑制剂在活性调节剂的经典酶碳酸酐酶的药物设计研究的一般背景下。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):561-580. doi: 10.1080/14756366.2021.1882453.
7
Insights into Potential Targets for Therapeutic Intervention in Epilepsy.癫痫治疗干预潜在靶点的研究进展。
Int J Mol Sci. 2020 Nov 13;21(22):8573. doi: 10.3390/ijms21228573.
8
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment.靶向代谢和肿瘤微环境的碳酸酐酶抑制剂
Metabolites. 2020 Oct 14;10(10):412. doi: 10.3390/metabo10100412.
9
Human carbonic anhydrases and post-translational modifications: a hidden world possibly affecting protein properties and functions.人类碳酸酐酶和翻译后修饰:一个可能影响蛋白质性质和功能的隐藏世界。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1450-1461. doi: 10.1080/14756366.2020.1781846.
10
Exploration of the residues modulating the catalytic features of human carbonic anhydrase XIII by a site-specific mutagenesis approach.通过定点突变方法探索调节人碳酸酐酶 XIII 催化特性的残基。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1506-1510. doi: 10.1080/14756366.2019.1653290.